Cellectar Biosciences Statistics
Total Valuation
CLRB has a market cap or net worth of $15.16 million. The enterprise value is $4.42 million.
Important Dates
The last earnings date was Thursday, August 14, 2025, before market open.
Earnings Date | Aug 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CLRB has 3.19 million shares outstanding. The number of shares has increased by 91.94% in one year.
Current Share Class | 3.19M |
Shares Outstanding | 3.19M |
Shares Change (YoY) | +91.94% |
Shares Change (QoQ) | +4.74% |
Owned by Insiders (%) | 1.08% |
Owned by Institutions (%) | 4.55% |
Float | 3.16M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.53 |
P/TBV Ratio | 2.70 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.15, with a Debt / Equity ratio of 0.06.
Current Ratio | 2.15 |
Quick Ratio | 1.88 |
Debt / Equity | 0.06 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -273.88% and return on invested capital (ROIC) is -216.70%.
Return on Equity (ROE) | -273.88% |
Return on Assets (ROA) | -111.74% |
Return on Invested Capital (ROIC) | -216.70% |
Return on Capital Employed (ROCE) | -491.93% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.64M |
Employee Count | 11 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, CLRB has paid $66,000 in taxes.
Income Tax | 66,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.52% in the last 52 weeks. The beta is 0.42, so CLRB's price volatility has been lower than the market average.
Beta (5Y) | 0.42 |
52-Week Price Change | -92.52% |
50-Day Moving Average | 5.67 |
200-Day Moving Average | 13.06 |
Relative Strength Index (RSI) | 46.55 |
Average Volume (20 Days) | 143,720 |
Short Selling Information
The latest short interest is 144,127, so 4.52% of the outstanding shares have been sold short.
Short Interest | 144,127 |
Short Previous Month | 66,900 |
Short % of Shares Out | 4.52% |
Short % of Float | 4.56% |
Short Ratio (days to cover) | 0.88 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -38.51M |
Pretax Income | -51.04M |
Net Income | -29.07M |
EBITDA | -38.26M |
EBIT | -38.51M |
Earnings Per Share (EPS) | -$24.83 |
Full Income Statement Balance Sheet
The company has $11.04 million in cash and $453,509 in debt, giving a net cash position of $10.59 million or $3.32 per share.
Cash & Cash Equivalents | 11.04M |
Total Debt | 453,509 |
Net Cash | 10.59M |
Net Cash Per Share | $3.32 |
Equity (Book Value) | 7.47M |
Book Value Per Share | 3.07 |
Working Capital | 6.75M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$34.58 million and capital expenditures -$61,286, giving a free cash flow of -$34.64 million.
Operating Cash Flow | -34.58M |
Capital Expenditures | -61,286 |
Free Cash Flow | -34.64M |
FCF Per Share | -$10.85 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |